Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06234501

Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism

Testing the Potential of High-dose Vitamin B6 Supplements for Sensory Reactivity in Autism

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Reading · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.

Detailed description

The main question it aims to answer is: * Does high-dose Vitamin B6 supplementation reduce sensory hyperreactivity differences in autism? * Does high-dose Vitamin B6 supplementation reduce anxiety differences in autism? * Explore the effects of vitamin B6 on sleep quality, Attention Deficit Hyperactivity Disorder (ADHD) scores, and various visual perception tasks that are indicative of GABAergic activity

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPyridoxal 5'-Phosphate (100 mg)100 mg Pyridoxal 5'-Phosphate tablet once daily with food
OTHERPlaceboPlacebo tablet once daily

Timeline

Start date
2024-11-08
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2024-01-31
Last updated
2026-03-11

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06234501. Inclusion in this directory is not an endorsement.